Purchase Order 36C26025P0874
- Not listed
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $112,012.72 contract is for the repair and preventative maintenance of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems used by the agency. There was no set-aside for this award. Illumina has previously provided...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 23 (VISN 23) of the Department of Veterans Affairs (VA) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $137,768.16, is for the provision of maintenance services for Illumina's NextSeq 2000 DNA sequencing platform at the Iowa City VA Health Care System. The contract has an ultimate completion date of...
- This is a $230,245.00 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for annual preventative maintenance and support services for the NextSeq sequencing platform located at the Boise VA Medical Center. The contract has an ultimate completion date of March 11, 2027 and was awarded on March 12, 2022. Illumina is a manufacturer and provider of genetic sequencing and analytical instruments and has supported similar requirements across...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 23 to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $179,000.00 contract provides for an ILLUMINA NEXSEQ 2000 SERVICE CONTRACT with a period of performance through October 2, 2029. This contract does not utilize any set-aside designations. The award represents a continuation of Illumina's...
- This federal contract award is for the purchase of a NEXTSEQ 550 SEQUENCING SYSTEM by the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The firm fixed-price contract, valued at $354,024.55, does not have a set-aside designation. Illumina has provided similar sequencing systems and consumables to other federal agencies such as the National Institutes of...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the Department of Veterans Affairs (VA) to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for a NextSeq 550DX Silver Support Plan, with a ceiling value of $217,263.00 and a completion date of September 17, 2029. The contract was awarded on September 18, 2025 and does not have a set-aside designation. Illumina is a leading provider of...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price purchase order to Illumina, Inc. for a NextSeq 550DX Sequencing System and associated supplies. This sole-source award was made on September 17, 2019, with a potential value of $342,242.72 and a completion date of September 16, 2020. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has previously provided similar products and services to federal agencies like...
- This is a firm fixed-price delivery order awarded to Illumina, Inc. by the Veterinary Services division of the U.S. Department of Veterans Affairs. The $90,150.80 contract is to provide annual service and preventative maintenance for the NextSeq 2000 sequencing system. The contract has no set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has supported sequencing needs across various federal agencies including NIH, CDC,...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract provides for the delivery of a NEXTSEQ 2000 Sequencing System and a NEXTSEQ 2000 Silver Support Plan, with a firm fixed price ceiling value of $276,513.69. The award was made on August 19, 2020, with a completion date of July 6, 2021. The contract was not set aside for any specific...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $48,209 firm fixed-price purchase order to Illumina, Inc. for maintenance and support services for an Illumina NextSeq 2000 Sequencing System. The contract, awarded on September 29, 2025, extends through September 28, 2026, and will be performed at the facility located in Boise, Idaho. This award does not utilize a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technology and maintenance services. Illumina, Inc., a San Diego-based biotechnology company, is a leading provider of genetic sequencing instruments, reagents, and related support services to federal agencies. The NextSeq 2000 is an advanced DNA and RNA sequencing platform used for genomic research and analysis. This maintenance and support plan ensures the Veterans Affairs facility can maintain optimal operational capability of its sequencing equipment to support laboratory operations, potentially including infectious disease research, diagnostics, and other genomic analysis initiatives that align with VA healthcare and research missions. Illumina maintains an extensive federal contracting portfolio across civilian and defense agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.2k | 9/4/25 |